Chemotherapy has long forced patients to choose between fighting their cancer and living with nerve pain that can linger for ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

Newron Pharmaceuticals further expands its intellectual property portfolio for Evenamide with a new EU composition of matter ...

Ad hoc announcement pursuant to Art. 53 LR Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is ...

Culture Partners, a global culture consulting firm known for helping organizations drive measurable business results through culture, today announced the Surrender to Lead Summit, a virtual leadership ...

Mark Toland, Chief Executive Officer of MMI, will present on Monday, January 12 at 9:00 AM PT, at the Westin St. Francis Hotel, Mission Bay meeting room. Toland will provide a company update with a ...

Ad hoc announcement pursuant to Art. 53 LR EP4615820 "Crystalline Forms of Evenamide" is expected to extend asset exclusivity in EU into 2044 Evenamide is currently being investigated in Newron's ...

A 67-year-old woman from Indore’s water contamination epicentre has developed Guillain-Barré syndrome-like symptoms after E.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Standard Market of the Tokyo Stock Exchange ...

Acupuncture's multi-pathway effects in ICU patients may reduce complications, support rehabilitation, and improve recovery ...

The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...